INDGN

Indegene Share Price

₹540.55 -7.2 (-1.31%)

02 May, 2025 09:40

SIP TrendupStart SIP in INDGN

Start SIP

Performance

  • Low
  • ₹535
  • High
  • ₹556
  • 52 Week Low
  • ₹470
  • 52 Week High
  • ₹736
  • Open Price₹556
  • Previous Close₹548
  • Volume60,977

Investment Returns

  • Over 1 Month -6.12%
  • Over 3 Month -11.28%
  • Over 6 Month -15.07%
  • Over 1 Year + 19.59%
SIP Lightning

Smart Investing Starts Here Start SIP with Indegene for Steady Growth!

Invest Now

Indegene Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 31.9
  • PEG Ratio
  • 1.5
  • Market Cap Cr
  • 12,974
  • P/B Ratio
  • 5.5
  • Average True Range
  • 22.54
  • EPS
  • 16.95
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.62
  • RSI
  • 44.3
  • MFI
  • 47.8

Indegene Financials

Indegene Technicals

EMA & SMA

Current Price
₹540.55
-7.2 (-1.31%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹562.85
  • 50 Day
  • ₹566.15
  • 100 Day
  • ₹579.51
  • 200 Day
  • ₹589.74

Resistance and Support

554 Pivot Speed
  • R3 586.50
  • R2 577.75
  • R1 562.75
  • S1 539.00
  • S2 530.25
  • S3 515.25

What's your outlook on Indegene?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Indegene is a global healthcare solutions company providing commercial, medical, and digital transformation services to life sciences companies. It helps pharmaceutical, biotech, and healthcare organizations enhance patient outcomes through data-driven strategies and innovative technology solutions.

Indegene Ltd has an operating revenue of Rs. 2,839.30 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 19% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 88 which is a GOOD score indicating consistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 80 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Indegene Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-04-28 Audited Results & Final Dividend
2025-01-30 Quarterly Results & Others To consider other business matters.
2024-10-28 Quarterly Results
2024-08-01 Quarterly Results
2024-05-29 Audited Results

Indegene F&O

Indegene Shareholding Pattern

0%
2.65%
0.04%
5.24%
0%
11.34%
80.73%

About Indegene

  • NSE Symbol
  • INDGN
  • BSE Symbol
  • 544172
  • ISIN
  • INE065X01017

Similar Stocks to Indegene

Indegene FAQs

Indegene share price is ₹540 As on 02 May, 2025 | 09:26

The Market Cap of Indegene is ₹12973.6 Cr As on 02 May, 2025 | 09:26

The P/E ratio of Indegene is 31.9 As on 02 May, 2025 | 09:26

The PB ratio of Indegene is 5.5 As on 02 May, 2025 | 09:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23